Answers are grounded in this paper and cite their sources.
There is common agreement on the desirability of developing new chemotherapeutic agents on a less empirical basis than that of testing miscellaneous compounds, but such an attempt is handicapped by inadequate knowledge of the metabolism of pathogenic organisms. The possibilities of other approaches are illustrated by the results of McIlwain and Hawking (1943) who showed that hemolytic streptococci which are known to require pantothenic acid for growth are inhibited in development both in vitro and in vivo by pantoyltaurine, an analogue of pantothenic acid. It was believed that if the nutritional requirements of Plasmodium gallinaceum were known, such information might be useful as a guide in the selection and synthesis of compounds to be tested as antimalarials. No satisfactory procedure for the in vitro cultivation of P. gallinaceum was available when this work began (Ball, et al, 1945) therefore, an investigation of its nutritional requirements was limited by the fact that in vivo cultivation must be used. A study of the pantothenic acid requirements of this parasite was chosen since the requirements of the host for this vitamin are well known (Jukes and McElroy, 1943) and since Mcllwain's data showed that analogues of pantothenic acid may have chemotherapeutic activity.
No takes yet. Share an insight, caveat, or question.
Brackett et al. (1946) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: